1428 10 (Farxiga 10 mg)
Generic Name: dapagliflozin
Pill with imprint 1428 10 is Yellow, Four-sided and has been identified as Farxiga 10 mg. It is supplied by Bristol-Myers Squibb Company.
Farxiga is used in the treatment of heart failure with reduced ejection fraction; diabetes, type 2; heart failure; chronic kidney disease and belongs to the drug class SGLT-2 inhibitors. Risk cannot be ruled out during pregnancy. Farxiga 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 1428 10
Farxiga
- Generic Name
- dapagliflozin
- Imprint
- 1428 10
- Strength
- 10 mg
- Color
- Yellow
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Sglt-2 inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb Company
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00003-1428 | |
| 00310-6210 | AstraZeneca |
More about Farxiga (dapagliflozin)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 115 Reviews
- Drug class: SGLT-2 inhibitors
- FDA Alerts (3)
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.